. Author manuscript; available in PMC: 2014 Jan 1.

Published in final edited form as: J Cardiovasc Pharmacol. 2013 Jan;61(1):17–22. doi: 10.1097/FJC.0b013e318274d2ef

TABLE 1.

Body weight, blood glucose, 24-h urine output, urinary sodium excretion (U_NaV), and systolic blood pressure (SBP) at the end of study in normoglycemic control and diabetic (DM) rats given vehicle or treated with amlodipine (DM+Amlo) or aliskiren (DM+Alisk) individually and combined (DM+Alisk+Amlo). n = 10 each group.

	Control	DM	DM+Amlo	DM+Alisk	DM+Amlo +Alisk
Body Weight (g)	480±11	300±20*	311±13*	297±11*	293±11*
Blood Glucose (mg/dl)	88±3	499±29*	488±19*	473±30*	459±25*
Urine Output (mL/d)	24±3	205±16*	184±9*	183±10*	175±10*
U_NaV (mmoL/d)	2.68±0.12	4.05±0.25*	3.93±0.16*	3.71±0.29*	3.61±0.22*
SBP (mm Hg)	112±0.4	113±0.5	112±0.5	113±1.6	112±0.3

P<0.05 vs. normoglycemic control.